Isoform-specific, Calcium-regulated Interaction of the Synaptic Vesicle Proteins SV2 and Synaptotagmin
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The identification and functional characterization of proteins localized to synaptic vesicles has contributed significantly to our understanding of neurotransmission. Studies of synaptic vesicle protein interactions have both led to the identification of novel synaptic proteins and suggested hypotheses of protein function. Synaptic vesicle protein 2 (SV2), is an integral membrane glycoprotein present in all synaptic vesicles. There are two characterized isoforms, SV2A and SV2B. Despite their homology to transporter proteins, the function of the SV2s remains unknown. In an effort to determine SV2 function and identify cofactors required for SV2 activity, we examined the protein interactions of SV2 using a combination of cross-linking, immunoprecipitation, and recombinant protein affinity chromatography. We report that SV2 is part of a large protein complex that contains the synaptic vesicle protein synaptotagmin. The interaction between SV2 and synaptotagmin is direct, specific to SV2A, and inhibited by calcium with an EC50 of approximately 10 microM. Interaction is mediated by the cytoplasmic amino terminus of SV2A and the C2B domain of synaptotagmin. Our observations suggest a regulatory relationship between these two proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synaptotagmin I: A major Ca2+ sensor for transmitter release at a central synapse
Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., & Südhof, T. C. (1994) · Cell · doi:10.1016/0092-8674(94)90556-8 · Cited by 1,483
A single C2 domain from synaptotagmin I is sufficient for high affinity Ca2+/phospholipid binding.
Davletov, B. A., & Südhof, T. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74326-9 · Cited by 480
SV2, a Brain Synaptic Vesicle Protein Homologous to Bacterial Transporters
Bajjalieh, S. M., Peterson, K., Shinghal, R., & Scheller, R. H. (1992) · Science · doi:10.1126/science.1519064 · Cited by 256
Self-citation
Cited by
Südhof, T. C. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131412 · Cited by 2,547
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Self-citationAbnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., & Bajjalieh, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15268 · Cited by 415
Self-citationThree-Dimensional Structure of the Synaptotagmin 1 C2B-Domain
Fernandez, I., Araç, D., Ubach, J., Gerber, S. H., Shin, O.-H., Gao, Y., Anderson, R. G. W., Südhof, T. C., & Rizo, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00548-7 · Cited by 389
How does calcium trigger neurotransmitter release?
Augustine, G. J. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00214-2 · Cited by 372
SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release
Janz, R., Goda, Y., Geppert, M., Missler, M., & Südhof, T. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)81046-6 · Cited by 367
SV2 modulates the size of the readily releasable pool of secretory vesicles
Xu, T., & Bajjalieh, S. M. (2001) · Nature Cell Biology · doi:10.1038/35087000 · Cited by 212
Self-citationSynaptic vesicle protein 2 enhances release probability at quiescent synapses
Custer, K. L., Austin, N. S., Sullivan, J. M., & Bajjalieh, S. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2699-05.2006 · Cited by 211
Self-citationMutch, S. A., Kensel-Hammes, P., Gadd, J. C., Fujimoto, B. S., Allen, R. W., Schiro, P. G., Lorenz, R. M., Kuyper, C. L., Kuo, J. S., Bajjalieh, S. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3805-10.2011 · Cited by 185
“Anti-synaptic vesicle protein 2 monoclonal antibody (SV2 mAb) (Buckley and Kelly, 1985) and anti-synaptotagmin polyclonal antibody (SYT pAb) (Schivell et al., 1996) recognize epitopes in the cytoplasmic domains of these proteins.”
BackgroundSelf-citationSV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis
Chang, W.-P., & Südhof, T. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4521-08.2009 · Cited by 176
“…with synaptotagmin, the Ca 2 sensor for exocytosis (Fernández-Chaćon et al., 2001; Sun et al., 2007), suggesting that SV2 acts by binding to synaptotagmin (Schivell et al., 1996), although the mode of interaction remains unclear (Pyle et al., 2000; Lazzell et al., 2004; Schivell et al., 2005).”
BackgroundInfluentialCotrafficking of SV2 and synaptotagmin at the synapse
Yao, J., Nowack, A., Kensel-Hammes, P., Gardner, R. G., & Bajjalieh, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4781-09.2010 · Cited by 164
“SV2 influences synaptotagmin 1 trafficking and expression SV2 is part of a large protein complex that includes the synaptic vesicle protein synaptotagmin 1 (Bennett et al., 1992; Schivell et al., 1996, 2005).”
BackgroundSelf-citationSynaptic vesicle protein 2A: basic facts and role in synaptic function
Mendoza‐Torreblanca, J. G., Vanoye‐Carlo, A., Phillips‐Farfán, B. V., Carmona‐Aparicio, L., & Gómez‐Lira, G. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12360 · Cited by 124
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123
“The binding is inhibited by increased calcium concentrations, probably because the interaction is regulated by calcium-induced conformational changes of synaptotagmin (Schivell et al., 1996).”
BackgroundPuzzling Out Synaptic Vesicle 2 Family Members Functions
Bartholome, O., Van den Ackerveken, P., Sánchez Gil, J., de la Brassinne Bonardeaux, O., Leprince, P., Franzen, R., & Rogister, B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00148 · Cited by 107
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance
Stout, K. A., Dunn, A. R., Hoffman, C., & Miller, G. W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00351 · Cited by 112
Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
Nowack, A., Malarkey, E. B., Yao, J., Bleckert, A., Hill, J., & Bajjalieh, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029560 · Cited by 81
“, suggest that levetiracetam may act by reversing the effects of increased SV2 expression. Because SV2 is part of a protein complex”
BackgroundSelf-citationZhang, N., Gordon, S. L., Fritsch, M. J., Esoof, N., Campbell, D. G., Gourlay, R., Velupillai, S., Macartney, T., Peggie, M., van Aalten, D. M. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4248-14.2015 · Cited by 72
“As mentioned in the Introduction, synaptotagmin-1 interacts with SV2A through its N-terminal domain (Schivell et al., 1996, 2005; Lazzell et al., 2004; Fig.”
BackgroundInfluentialMackler, J. M., & Reist, N. E. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1049 · Cited by 79
Kaempf, N., Kochlamazashvili, G., Puchkov, D., Maritzen, T., Bajjalieh, S. M., Kononenko, N. L., & Haucke, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501627112 · Cited by 63
“Second, the formation of SV protein assemblies (18, 36) may alleviate the need to specifically sort each SV component during every round of exo-/endocytosis and SV reformation.”
BackgroundSelf-citationEndocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations
Azarnia Tehran, D., López-Hernández, T., & Maritzen, T. (2019) · Cells · doi:10.3390/cells8111345 · Cited by 44
Integration of Synaptic Vesicle Cargo Retrieval with Endocytosis at Central Nerve Terminals
Cousin, M. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00234 · Cited by 38
Wu, P.-P., Cao, B.-R., Tian, F.-Y., & Gao, Z.-B. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-023-01138-2 · Cited by 35
Vogl, C., Tanifuji, S., Danis, B., Daniels, V., Foerch, P., Wolff, C., Whalley, B. J., Mochida, S., & Stephens, G. J. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12799 · Cited by 35
“, 1997) and the N-terminus of SV2A in a Ca-dependent manner (Schivell et al., 1996; Yao et al., 2010).”
BackgroundJoensuu, M., Syed, P., Saber, S. H., Lanoue, V., Wallis, T. P., Rae, J., Blum, A., Gormal, R. S., Small, C., Sanders, S., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112095 · Cited by 34
Bradberry, M. M., & Chapman, E. R. (2022) · The Journal of Physiology · doi:10.1113/jp282601 · Cited by 16
Structures of native SV2A reveal the binding mode for tetanus neurotoxin and anti-epileptic racetams
(2025) · doi:10.1038/s41467-025-59545-0 · Cited by 9
Targeting hippocampal amyloidogenesis with SV2A protein modulator levetiracetam
Kasatkina, L. A., Gumenyuk, V. P., Lisakovska, O. O., & Trikash, I. O. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114927 · Cited by 7
Hogg, J. A., & Cousin, M. A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16308 · Cited by 5
Metadata
- Authors
- Schivell, A. E., Batchelor, R. H., & Bajjalieh, S. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-11
- Volume
- 271
- Issue
- 44
- Pages
- 27770-27775
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2046505029
- Cited by
- 145
- References
- 3
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.